Angiogenic biomarkers of response to treatment with peptide receptor radionuclide therapy in neuroendocrine tumours.

Janusz StrzelczykMonika Wójcik-GiertugaKarolina MakulikVioletta RosiekGrzegorz KamińskiDariusz KajdaniukBeata Kos-Kudła

Published in: Endokrynologia Polska (2024)

VEGF-R1 may be a potential biomarker useful in assessing the effectiveness of PRRT in NET patients.

Keyphrases